US Patent

US10052337 — Compositions of obeticholic acid and methods of use

Formulation · Assigned to Intercept Pharmaceuticals Inc · Expires 2036-04-26 · 10y remaining

Vulnerability score 25/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects compositions of obeticholic acid, specifically formulations with improved stability, dissolution, and/or solubility.

USPTO Abstract

The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.

Drugs covered by this patent

Patent Metadata

Patent number
US10052337
Jurisdiction
US
Classification
Formulation
Expires
2036-04-26
Drug substance claim
No
Drug product claim
Yes
Assignee
Intercept Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.